Produkty 86377-53-9

CAS 86377-53-9 występuje w naszej ofercie pod nazwami: Ganoderic acid X, (3α,15α,24E)-15-(Acetyloxy)-3-hydroxylanosta-7,9(11),24-trien-26-oic acid, ≥95%, ≥95%. Oferty producentów: Biosynth, Chemat. Dostępne opakowania: 25mg, 10mg, 50mg, 5mg.

Ganoderic acid X
Biosynth
  • opakowanie: 25mg, 10mg, 50mg
  • Warianty: 3
Zobacz produkt
(3α,15α,24E)-15-(Acetyloxy)-3-hydroxylanosta-7,9(11),24-trien-26-oic acid, ≥95%, ≥95%
Chemat
  • opakowanie: 5mg
  • Warianty: 1
od 2872,40
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(E,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-15-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid (CAS 86377-53-9) to związek chemiczny o wzorze sumarycznym C32H48O5 i masie molowej 512.7 g/mol. Nazwa systematyczna IUPAC: (E,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-15-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid. InChIKey: YCWGPALSXRBKTM-XGNRZNIMSA-N.

Dane identyfikacyjne
Wzór sumarycznyC32H48O5
Masa molowa512.7 g/mol
Nazwa IUPAC(E,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-15-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid
InChIKeyYCWGPALSXRBKTM-XGNRZNIMSA-N
SMILESC[C@H](CC/C=C(\C)/C(=O)O)[C@H]1C[C@@H]([C@@]2([C@@]1(CC=C3C2=CC[C@@H]4[C@@]3(CC[C@H](C4(C)C)O)C)C)C)OC(=O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Ganoderic Acid X, orb1682524, 3alpha-hydroxy-15alpha-acetoxy-lanosta-7,9(11),24-trien-26-oic acid, (24E)-15alpha-(Acetyloxy)-3alpha-hydroxylanosta-7,9(11),24-trien-26-oic acid, (3|A,15|A,24E)-15-(Acetyloxy)-3-hydroxylanosta-7,9(11),24-trien-26-oic acid, (3I+/-,15I+/-,24E)-15-(Acetyloxy)-3-hydroxylanosta-7,9(11),24-trien-26-oic acid, Lanosta-7,9(11),24-trien-26-oic acid, 15-(acetyloxy)-3-hydroxy-, (3|A,15|A,24E)-
Powiązane formy tego związku
(E,6R)-6-[(3S,5R,10S,13R,14R,15S,17R)-15-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid C32H48O5
Izomery (ten sam wzór sumaryczny)
[(1S,2S,4S,5R,6S,9S,11R,14R,15S,18S,23R)-6,10,10,14,15,21,21-heptamethyl-25-oxo-3,24-dioxaheptacyclo[16.5.2.01,15.02,4.05,14.06,11.018,23]pentacosan-9-yl] acetate C32H48O5
butyl 1-[(E,1R,4R)-4-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-1-hydroxypent-2-enyl]cyclopropane-1-carboxylate C32H48O5
(3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bS)-3-acetyloxy-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid C32H48O5
(2R)-2-[(2R,3R,3aR,6S,7S,9bR)-2-hydroxy-6-(3-methoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydrocyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid C32H48O5
2-[(3S,5R,10S,13R,14R,16R,17R)-3-acetyloxy-16-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid C32H48O5
[(1R)-1-[(1S,2R,4S,6S,8R,13S,14S,19R)-1,2,8,14,18,18-hexamethyl-17-oxo-5-oxapentacyclo[11.8.0.02,10.04,9.014,19]henicosa-9,11-dien-6-yl]-2-hydroxy-2-methylpropyl] acetate C32H48O5
(1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bS)-10-acetyloxy-1,2,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,5,6,6a,7,8,8a,10,11,12,14b-tetradecahydropicene-4a-carboxylic acid C32H48O5
(E,5S,6S)-5-acetyloxy-6-[(3R,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid C32H48O5
(E)-6-(3-acetyloxy-15-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methylhept-2-enoic acid C32H48O5
2-[(1E,3Z,7E,9E)-13-[5-(2-hydroxyethyl)-3,5-dimethyloxolan-2-yl]-3,5,9,11-tetramethyl-12-oxotetradeca-1,3,7,9-tetraenyl]-3-methyl-2,3-dihydropyran-6-one C32H48O5